Regulations.gov document
2024-001086 - Eversio Wellness Ltd. - Eversio Wellness, Focus Now - improves…
Other · FDA-2024-S-0024 · posted Oct 3, 2024
Key facts
| Document ID | FDA-2024-S-0024-0355 |
|---|---|
| Title | 2024-001086 - Eversio Wellness Ltd. - Eversio Wellness, Focus Now - improves bioavailability and has a standardized potency of 35% beta-glucans in every serving |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2024-S-0024 |
| Posted | Oct 3, 2024 |
| Comment period opens | Oct 3, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: